Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;18(4):220261.
doi: 10.1183/20734735.0261-2022. Epub 2022 Dec 13.

Pulmonary vascular disease for the general respiratory clinician

Brian D Kent  1   2
Affiliations
Editorial

Pulmonary vascular disease for the general respiratory clinician

Brian D Kent. Breathe (Sheff). 2022 Dec.

Abstract

Pulmonary vascular disease is relevant to many practising respiratory clinicians: ∼1% of the world's population is estimated to have PH, and it is an important consequence of many other respiratory diseases (e.g. COPD, ILD, sleep breathing disorders) https://bit.ly/3hLqUx1.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: B.D. Kent has participated in advisory boards and/or received speaker fees from Astra Zeneca, Chiesi, GSK, Novartis, and Teva; has received educational travel bursaries from Boehringer Ingelheim, Chiesi, and Napp; and has received research funding from Itamar Medical.

Comment on

References

    1. Humbert M, Kovacs G, Hoeper MM, et al. . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2022; in press [10.1183/13993003.00879-2022]. - DOI - PubMed
    1. Lau EMT, Giannoulatou E, Celermajer DS, et al. . Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol 2017; 14: 603–614. doi:10.1038/nrcardio.2017.84 - DOI - PubMed
    1. Cullivan S, Higgins M, Gaine S. Diagnosis and management of pulmonary arterial hypertension. Breathe 2022; 18: 220168. doi:10.1183/20734735.0168-2022 - DOI - PMC - PubMed
    1. Blanco I, Gimeno E, Munoz PA, et al. . Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010; 181: 270–278. doi:10.1164/rccm.200907-0988OC - DOI - PubMed
    1. Krompa A, Marino P. Diagnosis and management of pulmonary hypertension related to chronic respiratory disease. Breathe 2022; in press [10.1183/20734735.0205-2022]. - DOI - PMC - PubMed

LinkOut - more resources